Gene · 1075
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of Neutrophil Elastase Inhibitors as Potential Therapies for ELANE Associated Neutropenia. | J Cell Immunol | 2024 | 39867870 | PubTator, text mining | PubMed |
| Multi-targeted olink proteomics analyses of cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage. | Proteome Sci | 2024 | 39604965 | PubTator, text mining | PubMed |
| PALS-14 promotes resistance to Nematocida parisii infection in Caenorhabditis elegans. | MicroPubl Biol | 2024 | 39473452 | PubTator, text mining | PubMed |
| Pharmacological inhibition of cathepsin S and of NSPs-AAP-1 (a novel, alternative protease driving the activation of neutrophil serine proteases). | Biochem Pharmacol | 2024 | 39455238 | PubTator, text mining | PubMed |
| Increased expression of cathepsin C in airway epithelia exacerbates airway remodeling in asthma. | JCI Insight | 2024 | 39436705 | PubTator, text mining | PubMed |
| Identification of novel indolinone derivatives as CTSC inhibitors to treat inflammatory bowel disease by modulating inflammatory factors. | Eur J Med Chem | 2024 | 39383651 | PubTator, text mining | PubMed |
| Cathepsin C Promotes Tumorigenesis in Bladder Cancer by Activating the Wnt/β-catenin Signalling Pathway. | Front Biosci (Landmark Ed) | 2024 | 39344330 | PubTator, text mining | PubMed |
| Novel cathepsin C inhibitor, BI 1291583, intended for treatment of bronchiectasis: Phase I characterization in healthy volunteers. | Clin Transl Sci | 2024 | 39175217 | PubTator, text mining | PubMed |
| Cathepsin C in health and disease: from structural insights to therapeutic prospects. | J Transl Med | 2024 | 39164687 | PubTator, text mining | PubMed |
| Cystatin F Depletion in Mycobacterium tuberculosis-Infected Macrophages Improves Cathepsin C/Granzyme B-Driven Cytotoxic Effects on HIV-Infected Cells during Coinfection. | Int J Mol Sci | 2024 | 39125711 | PubTator, text mining | PubMed |
| Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristics. | ERJ Open Res | 2024 | 39040578 | PubTator, text mining | PubMed |
| Genomic and transcriptomic profiling of inflammatory breast cancer reveals distinct molecular characteristics to non-inflammatory breast cancers. | Breast Cancer Res Treat | 2024 | 39030466 | PubTator, text mining | PubMed |
| Pharmacologic inhibition of dipeptidyl peptidase 1 (cathepsin C) does not block in vitro granzyme-mediated target cell killing by CD8 T or NK cells. | Front Pharmacol | 2024 | 39021839 | PubTator, text mining | PubMed |
| Identifying patients at risk of anaphylaxis. | World Allergy Organ J | 2024 | 38966605 | PubTator, text mining | PubMed |
| [Single-cell transcriptomic sequencing coupled with Mendelian randomization analysis elucidates the pivotal role of CTSC in chronic rhinosinusitis]. | Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | 2024 | 38965845 | PubTator, text mining | PubMed |
| Immune cell related signature predicts prognosis in esophageal squamous cell carcinoma based on single-cell and bulk-RNA sequencing. | Front Oncol | 2024 | 38903709 | PubTator, text mining | PubMed |
| Associations between multiple neurological biomarkers and distal sensorimotor polyneuropathy: KORA F4/FF4 study. | Diabetes Metab Res Rev | 2024 | 38872492 | PubTator, text mining | PubMed |
| Cathepsin C from extracellular histone-induced M1 alveolar macrophages promotes NETosis during lung ischemia-reperfusion injury. | Redox Biol | 2024 | 38861835 | PubTator, text mining | PubMed |
| Matrisome Transcriptome Dynamics during Tissue Aging. | Life (Basel) | 2024 | 38792614 | PubTator, text mining | PubMed |
| Design and evaluation of an immunology and pathology course that is tailored to today's dentistry students. | Front Oral Health | 2024 | 38783986 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1075/papers?page=9